Don’t miss out - Get your tickets early!

Join this FREE WEBINAR presented by Dr Peter Levine (USA).

TOPIC: How to Develop Resilience in the Human Spirit

EVENT DETAILS

DATE: 15th July 2026
TIME: 6:25pm (AEST) for 6:30pm start, finishing at 7:45pm
DURATION: 75 minutes (incl Q&A)
LOCATION: Online - a link will be emailed to you with the viewing details

ABOUT THE PRESENTER

Dr Peter Levine (USA)
Somatic Therapist and Founder of Somatic Experiencing®

Peter A Levine, Ph.D., is the developer of Somatic Experiencing®, a naturalistic and neurobiological approach to healing trauma, which he has developed over the past 50 years. He holds a doctorate in Biophysics from UC Berkeley and a doctorate in Psychology. He is the Founder and President of the Ergos Institute of Somatic Education and the Founder and Advisor for Somatic Experiencing International, where his work has been taught to almost 200,000 therapists in 44 countries.

He has taught at the University of California, Berkeley; Mills College; Antioch University; the California Institute of Integral Studies; and the Santa Barbara Graduate Institute, The Sigmund Freud University of Medicine in Vienna and the department of psychiatry at the school of medicine in Zurich Switzerland. He was a stress consultant for NASA on the early space shuttle mission.

He is the author of several landmark books on trauma, including Waking the Tiger, Healing Trauma (published in over 33 languages); In an Unspoken Voice, How the Body Releases Trauma and Restores Goodness; and Trauma and Memory, Brain and Body in a Search for the Living Past. And in 2025 published, An Autobiography of Trauma, A Healing Journey.

---

MEDICINAL PSYCHEDELIC TREATMENTS

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

SUPPORT PSYCHEDELIC RESEARCH AND THERAPY DEVELOPMENT

Your donation to Mind Medicine Australia will help us accelerate the availability and best practice of psychedelic-assisted psychotherapy in Australia. We are a small organisation doing big things – we need your support. Please click here to make a tax-deductible donation.

DISCLAIMER

Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms i.e. Facebook, Instagram or zoom private and public chat forms during the webinar. Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters. Mind Medicine Australia is focused specifically on the clinical application of medicinal psilocybin and medicinal MDMA for certain mental illnesses.